JAMP ALLOPURINOL TABLETS 200 MG — DIN 02534053
ALLOPURINOL : 200 MG · JAMP PHARMA CORPORATION · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is JAMP ALLOPURINOL TABLETS?
JAMP ALLOPURINOL TABLETS 200 MG contains ALLOPURINOL : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02534053, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 07-May-2024. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Allopurinol cost around the world?
Allopurinol is listed on 16 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 3 | 83 | USD███.██ |
| Australia | ex-manufacturer | 9 | 30 | AUD███.██ |
| South Africa | single exit price | 18 | 28 | ZAR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 15 | 20 | EUR███.██ |
| Sweden | AIP (pharmacy purchase price) | 6 | 18 | SEK███.██ |
| Czechia | max producer price (ex-factory) | 4 | 14 | CZK███.██ |
| Saudi Arabia | public | 11 | 12 | SAR███.██ |
| Morocco | PPV (public price) | 3 | 11 | MAD███.██ |
| Norway | max AUP (pharmacy retail) | 4 | 9 | NOK███.██ |
| United Arab Emirates | public | 6 | 7 | AED███.██ |
| Bahrain | retail (max) | 4 | 7 | BHD███.██ |
| Greece | producer price (ex-factory) | 7 | 7 | EUR███.██ |
| Luxembourg | reimbursement | 6 | 6 | EUR███.██ |
| Hungary | producer price (ex-factory) | 4 | 4 | HUF███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
| Romania | max producer price | 1 | 1 | RON███.██ |
259 pack listings across 103 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Allopurinol pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Allopurinol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
15 holders have a Canadian DIN containing Allopurinol, across 51 DINs, of which 12 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 7 | 3 | ALLOPURINOL, APO-ALLOPURINOL, APO-ALLOPURINOL TABLETS | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 6 | 3 | JAMP ALLOPURINOL, JAMP ALLOPURINOL TABLETS | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 6 | 3 | IPG-ALLOPURINOL, MAR-ALLOPURINOL | Sourceable in Canada |
| PRO DOC LIMITEE | 3 | 3 | ALLOPURINOL-100, ALLOPURINOL-200, ALLOPURINOL-300 | Sourceable in Canada |
| ANGITA PHARMA INC. | 3 | 0 | AG-ALLOPURINOL | No marketed DIN |
| CARTER-HORNER CORP. | 3 | 0 | PURINOL TAB 100MG, PURINOL TAB 200MG, PURINOL TAB 300MG | No marketed DIN |
| LABORATOIRES CONFAB INC | 3 | 0 | ALLOPURINOL TABLETS 100MG, ALLOPURINOL TABLETS 200MG, ALLOPURINOL TABLETS 300MG | No marketed DIN |
| NOVOPHARM LIMITED | 3 | 0 | NOVO-PUROL TAB 100MG, NOVO-PUROL TAB 200 MG, NOVO-PUROL TAB 300MG | No marketed DIN |
| NU-PHARM INC | 3 | 0 | NU-ALLOPURINOL | No marketed DIN |
| PHARMASCIENCE INC | 3 | 0 | PMS-ALLOPURINOL | No marketed DIN |
| TEVA CANADA LIMITED | 3 | 0 | NTP-ALLOPURINOL | No marketed DIN |
| VALEANT CANADA LP / VALEANT CANADA S.E.C. | 3 | 0 | ALLOPRIN | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Allopurinol |
|---|---|
| ATC code | M04AA01 |
| AHFS class | 92:16.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02534053 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2534053 |
| Brand name | JAMP ALLOPURINOL TABLETS |
| Generic / active ingredient | ALLOPURINOL : 200 MG |
| Market authorization holder | JAMP PHARMA CORPORATION |
| Health Canada schedule | Prescription |
| ATC code | M04AA01 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M04AA |
| Current status | CANCELLED PRE MARKET |
| Status date | 07-May-2024 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
12 of 51 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLOPURINOL-100 | 100 MG | TABLET | PRO DOC LIMITEE | MARKETED | 00555681 |
| ALLOPURINOL-200 | 200 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02130157 |
| ALLOPURINOL-300 | 300 MG | TABLET | PRO DOC LIMITEE | MARKETED | 00555703 |
| APO-ALLOPURINOL TABLETS | 100 MG | TABLET | APOTEX INC | MARKETED | 00402818 |
| APO-ALLOPURINOL TABLETS | 300 MG | TABLET | APOTEX INC | MARKETED | 00402796 |
| APO-ALLOPURINOL TABLETS | 200 MG | TABLET | APOTEX INC | MARKETED | 00479799 |
| JAMP ALLOPURINOL | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02421615 |
| JAMP ALLOPURINOL | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02421593 |
| JAMP ALLOPURINOL | 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02421607 |
| MAR-ALLOPURINOL | 300 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | 02396343 |
2 · Same class — other molecules in ATC M04AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Allopurinol | AG-ALLOPURINOL · ALLOPRIN · ALLOPURINOL · ALLOPURINOL TABLETS 100MG · +25 more | 51 | 12 | Yes |
| Febuxostat | AURO-FEBUXOSTAT · FEBUXOSTAT · JAMP FEBUXOSTAT · M-FEBUXOSTAT · +3 more | 7 | 6 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M04A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M04AC | Colchicine | 10 | 3 |
| M04AB | Probenecid · Sulfinpyrazone | 16 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is JAMP ALLOPURINOL TABLETS called?
The same molecule, Allopurinol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Zyloric | Latin | Bahrain, Morocco, Norway, Saudi Arabia |
| Allopurinol Sandoz | Latin | Australia, Norway, Sweden |
| MILURIT | Latin | Czechia |
| Zyloprim | Latin | Australia, South Africa |
| PURINOL | Latin | Czechia, Morocco |
| Allopurinol Nordic Drugs | Latin | Sweden |
| Allopurinol Orifarm | Latin | Sweden |
| Allopurinol Orion | Latin | Norway, Sweden |
| ALLOPURINOL-WGR | Latin | Australia |
| Allosig | Latin | Australia |
| APO-ALLOPURINOL | Latin | Australia |
| Progout Viatris | Latin | Australia |
| Puricos | Latin | South Africa |
| ALOPURINOL SANDOZ | Latin | Czechia |
| Redurate | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.